{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:00:42Z","timestamp":1761217242088},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T00:00:00Z","timestamp":1231891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s11010-008-0014-0","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T16:07:20Z","timestamp":1231862840000},"page":"201-206","source":"Crossref","is-referenced-by-count":7,"title":["The phosphorylation status of merlin in sporadic vestibular Schwannomas"],"prefix":"10.1007","volume":"324","author":[{"given":"Zhaoyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,14]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","volume":"278","author":"DH Gutmann","year":"1997","unstructured":"Gutmann DH, Aylsworth A, Carey JC et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51\u201357. doi: 10.1001\/jama.278.1.51","journal-title":"JAMA"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.54.1.71","volume":"54","author":"J Antinheimo","year":"2000","unstructured":"Antinheimo J, Sankila R, Carpen O et al (2000) Population-based analysis of sporadic and NF2-associated meningiomas and schwannomas. Neurology 54:71\u201376","journal-title":"Neurology"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0344-0338(96)80086-0","volume":"192","author":"EC Zwarthoff","year":"1996","unstructured":"Zwarthoff EC (1996) Neurofibromatosis and associated tumor suppressor genes. Pathol Res Pract 192:647\u2013657","journal-title":"Pathol Res Pract"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","volume":"12","author":"AI McClatchey","year":"1998","unstructured":"McClatchey AI, Saotome I, Mercer K et al (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12:1121\u20131133. doi: 10.1101\/gad.12.8.1121","journal-title":"Genes Dev"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","volume":"14","author":"M Giovannini","year":"2000","unstructured":"Giovannini M, Robanus-Maandag E, van der Valk M et al (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:1617\u20131630","journal-title":"Genes Dev"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/jbc.273.3.1273","volume":"273","author":"A Murthy","year":"1998","unstructured":"Murthy A, Gonzalez\u2013Agosti C, Cordero E et al (1998) NHE-RF, a regulatory cofactor for Na+-H+ exchange, is a common interactor for merlin and ERM proteins. J Biol Chem 273:1273\u20131276. doi: 10.1074\/jbc.273.3.1273","journal-title":"J Biol Chem"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1242\/jcs.110.18.2249","volume":"110","author":"M Sainio","year":"1997","unstructured":"Sainio M, Zhao F, Heiska L et al (1997) Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci 110:2249\u20132260","journal-title":"J Cell Sci"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s004010050608","volume":"93","author":"T Hitotsumatsu","year":"1997","unstructured":"Hitotsumatsu T, Iwaki T, Kitamoto T et al (1997) Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol 93:225\u2013232. doi: 10.1007\/s004010050608","journal-title":"Acta Neuropathol"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00005072-199704000-00007","volume":"56","author":"DP Huynh","year":"1997","unstructured":"Huynh DP, Mautner V, Baser ME et al (1997) Immunohistochemical detection of schwannomin and neurofibromin in vestibular Schwannomas, ependymomas and meningiomas. J Neuropathol Exp Neurol 56:382\u2013390. doi: 10.1097\/00005072-199704000-00007","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00005072-199706000-00011","volume":"56","author":"AO Stemmer-Rachamimov","year":"1997","unstructured":"Stemmer-Rachamimov AO, Gonzalez-Agosti C, Xu L et al (1997) Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system. J Neuropathol Exp Neurol 56:735\u2013742. doi: 10.1097\/00005072-199705000-00004","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR11","first-page":"2270","volume":"55","author":"M Lutchman","year":"1995","unstructured":"Lutchman M, Rouleau GA (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 55:2270\u20132274","journal-title":"Cancer Res"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1016\/S0021-9258(17)31525-9","volume":"269","author":"A Tikoo","year":"1994","unstructured":"Tikoo A, Varga M, Ramesh V et al (1994) An anti-Ras function of neurofibromatosis type 2 gene product (NF2\/Merlin). J Biol Chem 269:23387\u201323390","journal-title":"J Biol Chem"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","volume":"15","author":"H Morrison","year":"2001","unstructured":"Morrison H, Sherman LS, Legg J et al (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968\u2013980. doi: 10.1101\/gad.189601","journal-title":"Genes Dev"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/11.1.69","volume":"11","author":"KM Schulze","year":"2002","unstructured":"Schulze KM, Hanemann CO, Muller HW, Hanenberg H (2002) Transduction of wild-type merlin into human Schwannoma cells decreases Schwannoma cell growth and induces apoptosis. Hum Mol Genet 11:69\u201376. doi: 10.1093\/hmg\/11.1.69","journal-title":"Hum Mol Genet"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","volume":"15","author":"L Sherman","year":"1997","unstructured":"Sherman L, Xu HM, Geist RT et al (1997) Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene 15:2505\u20132509. doi: 10.1038\/sj.onc.1201418","journal-title":"Oncogene"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0962-8924(96)10030-1","volume":"6","author":"SJ Elledge","year":"1996","unstructured":"Elledge SJ, Winston J, Harper JW (1996) A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol 6:388\u2013392. doi: 10.1016\/0962-8924(96)10030-1","journal-title":"Trends Cell Biol"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-b-induced cell cycle arrest. Nature 371:257\u2013261. doi: 10.1038\/371257a0","journal-title":"Nature"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"Harper JW, Adami GR, Wei N et al (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclindependent kinases. Cell 75:805\u2013816. doi: 10.1016\/0092-8674(93)90499-G","journal-title":"Cell"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1101\/gad.9.15.1831","volume":"9","author":"I Reynisd\u00f3ttir","year":"1995","unstructured":"Reynisd\u00f3ttir I, Polyak K, Iavarone A, Massague J (1995) Kip\/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-b. Genes Dev 9:1831\u20131845. doi: 10.1101\/gad.9.15.1831","journal-title":"Genes Dev"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11010-006-9206-7","volume":"291","author":"JJ Tang","year":"2006","unstructured":"Tang JJ, Shen C, Lu YJ (2006) Requirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activation. Mol Cell Biochem 291:139\u2013144. doi: 10.1007\/s11010-006-9206-7","journal-title":"Mol Cell Biochem"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-2744(200009)29:1<1::AID-MC1>3.0.CO;2-A","volume":"29","author":"YJ Lu","year":"2000","unstructured":"Lu YJ, Tatsuka M, Takebe H, Yagi T (2000) Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells. Mol Carcinog 29:1\u20137 doi: 10.1002\/1098-2744(200009)29:1<l::AID-MC1>3.0.CO;2-A","journal-title":"Mol Carcinog"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.onc.1201585","volume":"16","author":"YJ Lu","year":"1998","unstructured":"Lu YJ, Yamagishi N, Yagi T, Takebe H (1998) Mutated p21WAF1\/CIP1\/SDI1 lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene 16:705\u2013712. doi: 10.1038\/sj.onc.1201585","journal-title":"Oncogene"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","volume":"67","author":"H Morrison","year":"2007","unstructured":"Morrison H, Sperka T, Manent J et al (2007) Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67:520\u2013527. doi: 10.1158\/0008-5472.CAN-06-1608","journal-title":"Cancer Res"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1083\/jcb.200503165","volume":"171","author":"T Okada","year":"2005","unstructured":"Okada T, Lopez-Lago M, Giancotti FG (2005) Merlin\/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol 171:361\u2013371. doi: 10.1083\/jcb.200503165","journal-title":"J Cell Biol"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1093\/carcin\/17.11.2343","volume":"17","author":"YJ Lu","year":"1996","unstructured":"Lu YJ, Yamagishi N, Miyakoshi J et al (1996) Sites and types of UV-induced mutations leading to inactivation of the growth-arresting activity in p21 (waf1)(sdi1\/cip1\/waf1) cDNA. Carcinogenesis 17:2343\u20132345. doi: 10.1093\/carcin\/17.11.2343","journal-title":"Carcinogenesis"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","volume":"25","author":"GH Xiao","year":"2005","unstructured":"Xiao GH, Gallagher R, Shetler J et al (2005) The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol 25:2384\u20132394. doi: 10.1128\/MCB.25.6.2384-2394.2005","journal-title":"Mol Cell Biol"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature04856","volume":"442","author":"H Jin","year":"2006","unstructured":"Jin H, Sperka Y, Herrlich P, Morrison H (2006) Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase. Nature 442:576\u2013579. doi: 10.1038\/nature04856","journal-title":"Nature"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1016-8478(23)15080-1","volume":"14","author":"H Kim","year":"2002","unstructured":"Kim H, Lim JY, Kim YH et al (2002) Inhibition of Ras-mediated activator protein 1 activity and cell growth by merlin. Mol Cells 14:108\u2013114","journal-title":"Mol Cells"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","volume":"1","author":"RJ Shaw","year":"2001","unstructured":"Shaw RJ, Paez JG, Curto M et al (2001) The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 1:63\u201372. doi: 10.1016\/S1534-5807(01)00009-0","journal-title":"Dev Cell"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1074\/jbc.C100553200","volume":"277","author":"GH Xiao","year":"2002","unstructured":"Xiao GH, Beeser A, Chernoff J, Testa JR (2002) p21-activated kinase links Rac\/Cdc42 signaling to merlin. J Biol Chem 277:883\u2013886. doi: 10.1074\/jbc.C100553200","journal-title":"J Biol Chem"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1073\/pnas.0510651103","volume":"103","author":"DN Chadee","year":"2006","unstructured":"Chadee DN, Xu DZ, Hung G et al (2006) Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf\/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci USA 103:4463\u20134468. doi: 10.1073\/pnas.0510651103","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","volume":"101","author":"LR Rong","year":"2004","unstructured":"Rong LR, Tang XL, Gutmann DH, Ye K (2004) Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE. Proc Natl Acad Sci USA 101:18200\u201318205. doi: 10.1073\/pnas.0405971102","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-008-0014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-008-0014-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-008-0014-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:54:58Z","timestamp":1709945698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-008-0014-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,14]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11010-008-0014-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,14]]}}}